Company Filing History:
Years Active: 2025
Title: The Innovations of Patrick R. Mayo
Introduction
Patrick R. Mayo is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of fibrosis. His innovative approach has led to the development of a unique patent that showcases his expertise and dedication to improving health outcomes.
Latest Patents
Patrick R. Mayo holds a patent for the "Use of cyclosporine analogues for treating fibrosis." This patent discloses methods, compositions, and kits suitable for preventing, treating, or reversing fibrosis. The methods involve administering a composition that includes a cyclosporine analogue, such as CRV431, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof. This innovative approach has the potential to significantly impact the treatment of fibrosis.
Career Highlights
Patrick R. Mayo is currently associated with Hepion Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development. His career is marked by a commitment to advancing medical science and improving patient care through innovative solutions.
Collaborations
Some of his notable coworkers include Daren R. Ure and Daniel J. Trepanier. Their collaboration has contributed to the success of various projects within the company, fostering an environment of innovation and teamwork.
Conclusion
Patrick R. Mayo's contributions to the field of medicine through his patent and work at Hepion Pharmaceuticals, Inc. highlight his role as a leading inventor in the treatment of fibrosis. His innovative methods and dedication to research continue to pave the way for advancements in healthcare.